227. Osler disease
49 clinical trials,   69 drugs   (DrugBank: 21 drugs),   23 drug target genes,   132 drug target pathways

Searched query = "Osler disease", "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04113187
(ClinicalTrials.gov)
June 23, 202027/9/2019Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia PatientsStudy of the Efficacy of Propranolol for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia PatientsHereditary Hemorrhagic Telangiectasia;Osler Weber Rendu DiseaseDrug: Propranolol treatment;Drug: PlaceboUniversity Hospital, BordeauxAMRO-HHT-France - Association Maladie de Rendu-OslerRecruiting18 YearsN/AAll38Phase 3France